Potempa LA - Search Results

1

Tubular staining of modified C-reactive protein in diabetic chronic kidney disease.

Schwedler SB, Guderian F, Dämmrich J, Potempa LA, Wanner C. Schwedler SB, et al. Among authors: potempa la. Nephrol Dial Transplant. 2003 Nov;18(11):2300-7. doi: 10.1093/ndt/gfg407. Nephrol Dial Transplant. 2003. PMID: 14551357

2

Native C-reactive protein increases whereas modified C-reactive protein reduces atherosclerosis in apolipoprotein E-knockout mice.

Schwedler SB, Amann K, Wernicke K, Krebs A, Nauck M, Wanner C, Potempa LA, Galle J. Schwedler SB, et al. Among authors: potempa la. Circulation. 2005 Aug 16;112(7):1016-23. doi: 10.1161/CIRCULATIONAHA.105.556530. Epub 2005 Aug 8. Circulation. 2005. PMID: 16087790

3

C-reactive protein: a family of proteins to regulate cardiovascular function.

Schwedler SB, Filep JG, Galle J, Wanner C, Potempa LA. Schwedler SB, et al. Among authors: potempa la. Am J Kidney Dis. 2006 Feb;47(2):212-22. doi: 10.1053/j.ajkd.2005.10.028. Am J Kidney Dis. 2006. PMID: 16431250 Review.

4

Native C-reactive protein induces endothelial dysfunction in ApoE-/- mice: implications for iNOS and reactive oxygen species.

Schwedler SB, Kuhlencordt PJ, Ponnuswamy PP, Hatiboglu G, Quaschning T, Widder J, Wanner C, Potempa LA, Galle J. Schwedler SB, et al. Among authors: potempa la. Atherosclerosis. 2007 Dec;195(2):e76-84. doi: 10.1016/j.atherosclerosis.2007.06.013. Epub 2007 Jul 31. Atherosclerosis. 2007. PMID: 17669410

5

Monomeric C-reactive protein decreases acetylated LDL uptake in human endothelial cells.

Schwedler SB, Hansen-Hagge T, Reichert M, Schmiedeke D, Schneider R, Galle J, Potempa LA, Wanner C, Filep JG. Schwedler SB, et al. Among authors: potempa la. Clin Chem. 2009 Sep;55(9):1728-31. doi: 10.1373/clinchem.2009.125732. Epub 2009 Jul 17. Clin Chem. 2009. PMID: 19617288

6

Complement activation by C-reactive protein on the HEp-2 cell substrate.

Vaith P, Prasauskas V, Potempa LA, Peter HH. Vaith P, et al. Among authors: potempa la. Int Arch Allergy Immunol. 1996 Oct;111(2):107-17. doi: 10.1159/000237354. Int Arch Allergy Immunol. 1996. PMID: 8859218

7

Conversion of native oligomeric to a modified monomeric form of human C-reactive protein.

Kresl JJ, Potempa LA, Anderson BE. Kresl JJ, et al. Among authors: potempa la. Int J Biochem Cell Biol. 1998 Dec;30(12):1415-26. doi: 10.1016/s1357-2725(98)00078-8. Int J Biochem Cell Biol. 1998. PMID: 9924810

8

Inhibition of mouse mammary adenocarcinoma (EMT6) growth and metastases in mice by a modified form of C-reactive protein.

Kresl JJ, Potempa LA, Anderson B, Radosevich JA. Kresl JJ, et al. Among authors: potempa la. Tumour Biol. 1999 Mar-Apr;20(2):72-87. doi: 10.1159/000030050. Tumour Biol. 1999. PMID: 10050106

9

Production of modified C-reactive protein in U937-derived macrophages.

Ciubotaru I, Potempa LA, Wander RC. Ciubotaru I, et al. Among authors: potempa la. Exp Biol Med (Maywood). 2005 Nov;230(10):762-70. doi: 10.1177/153537020523001010. Exp Biol Med (Maywood). 2005. PMID: 16246904

10

C-reactive protein and inflammation: conformational changes affect function.

Wu Y, Potempa LA, El Kebir D, Filep JG. Wu Y, et al. Among authors: potempa la. Biol Chem. 2015 Nov;396(11):1181-97. doi: 10.1515/hsz-2015-0149. Biol Chem. 2015. PMID: 26040008 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters